U.S.: FTC, animal health co reach agreement on distribution exclusivity deals
IDEXX Laboratories Inc has signed a Consent Agreement with the Federal Trade Commission to settle an investigation into whether the diagnostics and information technology solutions company had hampered competition. The company specializes in animal health as well as water and milk supply quality. Under terms of the agreement, IDEXX can no longer have exclusive distribution contracts with three veterinary companies at once. The three companies named are MWI Veterinary Supply, Inc., Butler Schein Animal Health and Webster Veterinary. The agreement says that IDEXX can maintain those exclusivity agreements with two at once, however. IDEXX has not admitted to any legal misdoings, and its CEO and chairman Jonathan Ayers said in a statement that the agreement is a “milestone” in resolving the investigation.
Featured News
Tech Policy and Regulation Weekly Roundup
Jan 23, 2026 by
CPI
Perkins Coie Adds Former DOJ Antitrust Leader as Partner in Washington
Jan 22, 2026 by
CPI
Ryanair Boss Dismisses Musk’s Buyout as Starlink Feud Escalates
Jan 22, 2026 by
CPI
Paramount Extends Warner Bros Bid as Netflix Rivalry Heats Up
Jan 22, 2026 by
CPI
South Korea Breaks New Ground With Landmark AI Law
Jan 22, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Recidivism
Jan 21, 2026 by
CPI
Recidivism, Multiple Offending, and Serial Offending in Antitrust
Jan 21, 2026 by
Gregory Werden
Antitrust Recidivism: Why Repeat Cases Appear, and Why True Reoffending Is Rare in the United States
Jan 21, 2026 by
Lisa M. Phelan, Megan S. Golden, Adrienne Irmer & Nina Worth
99 Antitrust Problems – Is Recidivism One?
Jan 21, 2026 by
Brian A. Ratner & Kartik S. Madiraju
Holding A Cat by the Tail: A View of Cartel Recidivism in U.S. Antitrust Enforcement
Jan 21, 2026 by
Mark Rosman & KaDee L. Ru